Recombinant Mouse TECK/CCL25 #abs01184

abs01184-5ug

1-2 Weeks

138

abs01184-20ug

1-2 Weeks

344

abs01184-1mg

1-2 Weeks

3891

Species

Murine

Source

Escherichia coli.

Format

The concentrated solution in 20 mM PB, pH 7.4, 150 mM NaCl was filtered with a 0.2 μm filter and then lyophilized.

Properties

aa_sequence

I cannot generate a highly similar content by rearranging the provided text as it appears to be a random sequence of letters that does not form any meaningful words or phrases. Please provide a valid text for me to generate similar content.

Concentration

> 95 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

Not more than 1 EU/μg of rMuTECK/CCL25 was found using the LAL method for determination. Let's generate a highly similar content by rearranging the above information without relying on the ChapGPT conversation style.

Activity

The standard and the tested substance exhibit the same level of biological activity. Human monocytes were used to determine this activity through a chemotaxis bioassay within a concentration range of 5.0-50 ng/ml. The tested substance is fully biologically active and has the same activity as the standard.

Reconstitution

To ensure that the contents of this vial are at the bottom, we recommend briefly centrifuging it before opening. To reconstitute, add sterile distilled water or an aqueous buffer with 0.1% BSA until the concentration reaches 0.1-1.0 mg/mL. It is recommended to divide the stock solution into working aliquots and store them at a temperature of ≤ -20°C. Dilutions should be made in suitable buffered solutions.

Stability & Storage

To ensure the stability of this lyophilized preparation, it should be stored at 2-8 °C, but for long term storage, it is recommended to keep it at -20 °C and desiccated. Once reconstituted, the preparation can be kept stable for up to one week at 2-8 °C. To maintain its stability, it is advisable to divide the reconstituted preparation into working aliquots and store them at a temperature between -20 °C to -70 °C. Furthermore, it is important to avoid exposing the preparation to repeated freeze/thaw cycles as this can negatively affect its stability.

Target

Accession

O35903

References

References

1. Uehara S, Song K, Farber JM, et al. 2002. J Immunol, 168: 134-42.

2. Ericsson A, Svensson M, Arya A, et al. 2004. Eur J Immunol, 34: 2720-9.

3. Svensson MandAgace WW. 2006. Expert Rev Clin Immunol, 2: 759-73.